Jonathan L Kaufman Selected Research

PVX-410 vaccine

12/2018

Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma: A Nonrandomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan L Kaufman Research Topics

Disease

76	Multiple Myeloma 04/2024 - 04/2006
11	Neoplasms (Cancer) 04/2024 - 01/2006
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 06/2012
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 04/2012
5	Lymphoma (Lymphomas) 06/2014 - 04/2006
4	Disease Progression 01/2022 - 06/2012
4	Hematologic Neoplasms (Hematological Malignancy) 06/2014 - 08/2011
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 07/2012
3	Infections 02/2022 - 01/2012
3	Fatigue 01/2016 - 08/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 04/2024 - 01/2017
2	Cytokine Release Syndrome 12/2023 - 01/2023
2	Smoldering Multiple Myeloma 10/2020 - 12/2018
2	Immunoglobulin Light-chain Amyloidosis 01/2020 - 01/2018
2	Anemia 11/2018 - 01/2016
2	Thrombocytopenia (Thrombopenia) 01/2016 - 10/2014
2	Injection Site Reaction 09/2013 - 06/2009
2	Virus Diseases (Viral Diseases) 01/2012 - 02/2004
2	Renal Insufficiency (Renal Failure) 02/2008 - 03/2007
1	Obesity 01/2023
1	Diabetes Mellitus 01/2023
1	cell-associated neurotoxicity 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023
1	Plasmablastic Lymphoma 01/2023
1	Breakthrough Infections 01/2023
1	Thrombosis (Thrombus) 11/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2021
1	Myocarditis (Carditis) 01/2018
1	Amyloid Plaque 01/2018
1	Plasma Cell Leukemia 01/2017
1	Neutropenia 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2016
1	Diarrhea 01/2016
1	Nausea 01/2016
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2015

Drug/Important Bio-Agent (IBA)

34	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 07/2010
29	Bortezomib (Velcade)FDA Link 04/2024 - 04/2006
26	Lenalidomide (CC 5013)FDA Link 04/2024 - 08/2010
19	daratumumabIBA 04/2024 - 01/2017
7	venetoclaxIBA 11/2021 - 11/2017
7	Proteasome InhibitorsIBA 01/2019 - 03/2007
6	Proteins (Proteins, Gene)FDA Link 10/2023 - 08/2011
6	Monoclonal AntibodiesIBA 12/2020 - 01/2006
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018 - 06/2009
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 04/2012
5	plerixafor FDA Link 01/2018 - 06/2009
5	Rituximab (Mabthera)FDA Link 11/2015 - 04/2012
4	carfilzomibIBA 10/2021 - 06/2012
3	ixazomibIBA 12/2022 - 12/2014
3	elotuzumabIBA 06/2022 - 06/2012
3	Immunoglobulins (Immunoglobulin)IBA 02/2022 - 08/2013
3	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 04/2014
3	filanesibIBA 01/2022 - 11/2016
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2013
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 04/2006
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2015 - 04/2012
3	Vincristine (Oncovin)FDA LinkGeneric 11/2015 - 04/2012
2	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2023
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023 - 01/2023
2	AntigensIBA 01/2023 - 01/2023
2	B-Cell Maturation AntigenIBA 01/2023 - 01/2023
2	Thalidomide (Thalomid)FDA Link 01/2023 - 07/2010
2	VaccinesIBA 01/2023 - 10/2022
2	KinesinsIBA 01/2022 - 11/2016
2	Histone Deacetylase InhibitorsIBA 12/2020 - 08/2013
2	Vorinostat FDA Link 12/2020 - 01/2016
2	PanobinostatIBA 01/2019 - 10/2014
2	Prednisone (Sone)FDA LinkGeneric 11/2015 - 07/2012
1	Adenosine Monophosphate (AMP)IBA 04/2024
1	Surface Antigens (Surface Antigen)IBA 01/2024
1	Bispecific AntibodiesIBA 01/2024
1	tocilizumab (atlizumab)FDA Link 12/2023
1	Neutralizing AntibodiesIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	vinyltriethoxysilane (VTES)IBA 11/2022
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2022
1	Pregabalin (Lyrica)FDA Link 01/2022
1	Immunoglobulin M (IgM)IBA 11/2021
1	vendexIBA 01/2021
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 01/2021
1	isatuximabIBA 12/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019
1	PVX-410 vaccineIBA 12/2018
1	pomalidomideIBA 01/2017
1	Immunoglobulin G (IgG)IBA 03/2016
1	CreatinineIBA 03/2016
1	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 01/2016
1	marizomibIBA 01/2016
1	ParaproteinsIBA 03/2015

Therapy/Procedure

34	Therapeutics 04/2024 - 04/2006
10	Stem Cell Transplantation 10/2023 - 06/2009
5	Transplantation 10/2023 - 01/2013
4	Immunotherapy 01/2024 - 11/2013
4	Hematopoietic Stem Cell Mobilization 01/2023 - 08/2011
3	Hematopoietic Stem Cell Transplantation 01/2018 - 04/2014
2	Drug Tapering 01/2023 - 11/2015
2	Blood Component Removal (Apheresis) 09/2013 - 08/2011
1	Radiotherapy 01/2018
1	Immunomodulation 01/2017
1	Drug Therapy (Chemotherapy) 02/2015